Blackpool Council adult social care services 'inadequate'
Inspectors looked at nine areas of the service and gave them a score out of four - with one being where "the evidence showed significant shortfalls", and four where it "showed an exceptional standard".Blackpool Council scored one in six of the areas and two in the remaining three.
'Unexpected'
The watchdog noted that people who identified as LGBTQIA+ "received a different standard of care and support compared to people with less bespoke needs".Councillor Neal Brookes, deputy leader of Blackpool Council and cabinet member for adult social care, said he was shocked by these findings.He said: "Up until the CQC report landed, we worked on the national metric, [and] in two thirds of them we were good or above average. "We don't accept that things ever stand still, but we didn't expect inadequate."He added there was no evidence of adults being unsafe. James Bullion, the CQC's chief inspector of adult social care and integrated care, said there needed to be stronger leadership.Brookes added: "We've already moved to bring in new people, because we need an outside perspective. We need to collect what's being done well elsewhere. "Obviously in any change programme there are consequences. It's too early to say what those are."
Listen to the best of BBC Radio Lancashire on Sounds and follow BBC Lancashire on Facebook, X and Instagram. You can also send story ideas via Whatsapp to 0808 100 2230.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
30 minutes ago
- The Independent
This new SPF from ESPA hydrates, protects and leaves skin naturally radiant with 92% of users agreeing
There's something quietly reassuring about a solid skincare routine, especially when it doesn't require a dozen complicated steps or leave you feeling slick. Still, for many of us SPF is the step that gets forgotten, skipped or reserved for holidays abroad. And who can blame us? Traditional sunscreens can feel chalky, greasy or leave behind a ghostly, stubborn white cast. The thing is: protecting your skin isn't just about beach days. With UV rays, blue light from screens and urban pollution all contributing to premature ageing, SPF really is an everyday essential – whether you're sitting on a sun-drenched patio or just replying to emails indoors. Enter ESPA's new Protect & Brighten Daily Skin Shield SPF 50 (£40, Designed to slot seamlessly into your morning routine, it promises comfortable and lightweight protection, and leaves your skin with a natural luminosity that looks fresh, not filtered. In fact, 92 per cent of users said it gave their skin a visible dewy glow. For those concerned about signs of ageing, or simply wanting to maintain a youthful-looking complexion, this may well be the SPF you've been searching for. So, what makes it stand out in a sea of sun protection? And what's behind these glow-giving claims? Let's take a look. More than sun care Unlike heavy-duty sunscreen sprays that sit on top of the skin, ESPA's Skin Shield is formulated like a luxurious moisturiser that just so happens to include SPF 50. It's powered by hydrating hyaluronic acid, antioxidant-rich beta carotene and Chinese butterfly bush extract, which help to defend against UV rays, blue light and pollution. Together, they offer more than just sun protection: they soothe, hydrate and actively help to reduce the visible signs of ageing. From fine lines to sun spots and uneven tone, the daily aggressors this product guards against are relevant year-round – not just during a heatwave. And because the texture is so lightweight and non-greasy, it layers easily over your existing moisturiser or under make-up (if you're wearing any), without pilling or feeling cakey. A 3-in-1 primer, protector and glow-booster The real beauty of ESPA's Skin Shield lies in its finish. Fast-absorbing and silky, it gives skin a subtle radiance that leaves you looking lit-from-within, naturally and without the strobe effect of a highlighter or shimmer. There's no white cast, no stickiness or even the sensation that you're wearing anything. It's the kind of multi-tasker we look to in the summer months: simplifying your morning routine but sacrificing neither sun protection nor skin smoothing. You can use it as your final skincare step, a smoothing primer or the one thing you slap on if you're running out the door. According to user trials, 96 per cent agreed their skin looked brighter after just two weeks of use and 83 per cent said fine lines and wrinkles appeared softened. For a no-makeup-makeup look, this one's doing the heavy lifting. For all skin types and every kind of day One of the biggest pain points with SPF is inclusivity, and ESPA has paid attention here. Skin Shield is wearable on all tones and textures, from dry and sensitive to oily or blemish-prone. It doesn't clog, flake or fight your base, and it's as comfortable for long hikes as it is for commuting. Add in the fact that you're getting broad-spectrum UVA/UVB coverage and oxidative stress protection in one simple step, and it starts to feel less like a luxury and more like a non-negotiable. Plus, with 20 per cent off (was £50, now £40, it's a timely excuse to elevate your skincare essentials before the seasons shift.
The Independent
30 minutes ago
- The Independent
Researchers find milk type that increases risk of heart disease and death
A 33-year study conducted in Norway has investigated the long-term health impacts of consuming full-fat versus low-fat milk. Researchers analysed health data from 73,860 individuals, finding that the fat content of milk influenced the risk of death from heart disease. The study revealed that individuals who consumed full-fat milk had a higher mortality risk compared to those who drank low-fat milk. Specifically, consuming low-fat milk was linked to an 11 per cent lower overall mortality risk and a 7 per cent reduced risk of cardiovascular disease compared to whole milk. These findings support current NHS health advice, which cautions against high intake of saturated fat found in full-fat dairy due to its link to increased cholesterol and heart disease risk.
BBC News
31 minutes ago
- BBC News
Daily weight loss pill helps patients lose 12% of body weight
Trials of a daily obesity pill have shown it can help patients lose around 12% of their body weight over 72 weeks. The manufacturer, Eli Lilly, says the drug, which is not yet licensed, could be available next daily pill, called orforglipron, works by suppressing appetite and making you feel more results of a major trial show those on the highest dose lost an average of 12 kilos (nearly two stone) over 16 months but about one in 10 stopped taking the pills due to side effects, including nausea and vomiting. In addition to weight loss, participants also benefited from reductions in cholesterol, blood fats and blood Kenneth Custer of Eli Lilly said the company was planning to submit the drug for licensing before the end of the year and preparing for a "global launch to address this urgent pubic health need".So where might this weight loss pill fit in to the blockbuster multi-billion pound market dominated by injectable drugs like Mounjaro, Wegovy and Ozempic?The pill is much less effective than 12% weight loss achieved by those taking orforglipron compares to 22% weight loss for patients on Mounjaro, given by weekly injection. Both drugs are made by Eli Lilly. Despite being less effective, there is likely to be a significant market for weight loss pills, as a needle-free means of cutting obesity experts hope the oral drug will be far cheaper than current injectables which would make it available to many more patients. The full results of the trial will be presented next month at the European Association for the Study of Diabetes annual meeting and published in a peer-reviewed manufacturer, Novo Nordisk, also has an oral version of its injectable drug Wegovy which it has already submitted for approval in the trials, patients on the highest dose of the Novo Nordisk daily pill lost around 15% of their bodyweight after 64 weeks.
